Literature DB >> 6189183

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

F Barré-Sinoussi, J C Chermann, F Rey, M T Nugeyre, S Chamaret, J Gruest, C Dauguet, C Axler-Blin, F Vézinet-Brun, C Rouzioux, W Rozenbaum, L Montagnier.   

Abstract

A retrovirus belonging to the family of recently discovered human T-cell leukemia viruses (HTLV), but clearly distinct from each previous isolate, has been isolated from a Caucasian patient with signs and symptoms that often precede the acquired immune deficiency syndrome (AIDS). This virus is a typical type-C RNA tumor virus, buds from the cell membrane, prefers magnesium for reverse transcriptase activity, and has an internal antigen (p25) similar to HTLV p24. Antibodies from serum of this patient react with proteins from viruses of the HTLV-I subgroup, but type-specific antisera to HTLV-I do not precipitate proteins of the new isolate. The virus from this patient has been transmitted into cord blood lymphocytes, and the virus produced by these cells is similar to the original isolate. From these studies it is concluded that this virus as well as the previous HTLV isolates belong to a general family of T-lymphotropic retroviruses that are horizontally transmitted in humans and may be involved in several pathological syndromes, including AIDS.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6189183     DOI: 10.1126/science.6189183

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  1436 in total

1.  Effects of soluble CD4 on simian immunodeficiency virus infection of CD4-positive and CD4-negative cells.

Authors:  D Schenten; L Marcon; G B Karlsson; C Parolin; T Kodama; N Gerard; J Sodroski
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 2.  Epidemiology and prevention of AIDS in children.

Authors:  J P Narain; G Sodhi
Journal:  Indian J Pediatr       Date:  1995 May-Jun       Impact factor: 1.967

3.  A human myeloma cell line suitable for the generation of human monoclonal antibodies.

Authors:  A Karpas; A Dremucheva; B H Czepulkowski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

4.  Unique progressive cleavage mechanism of HIV reverse transcriptase RNase H.

Authors:  M Wisniewski; M Balakrishnan; C Palaniappan; P J Fay; R A Bambara
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

5.  25 years of HIV in New York City: lessons from surveillance.

Authors: 
Journal:  J Urban Health       Date:  2001-12       Impact factor: 3.671

6.  A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago.

Authors:  F R Cleghorn; N Jack; J K Carr; J Edwards; B Mahabir; A Sill; C B McDanal; S M Connolly; D Goodman; R Q Bennetts; T R O'Brien; K J Weinhold; C Bartholomew; W A Blattner; M L Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

7.  CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5.

Authors:  Aarti Raja; Miro Venturi; Peter Kwong; Joseph Sodroski
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

8.  Experimental Adaptive Evolution of Simian Immunodeficiency Virus SIVcpz to Pandemic Human Immunodeficiency Virus Type 1 by Using a Humanized Mouse Model.

Authors:  Kei Sato; Naoko Misawa; Junko S Takeuchi; Tomoko Kobayashi; Taisuke Izumi; Hirofumi Aso; Shumpei Nagaoka; Keisuke Yamamoto; Izumi Kimura; Yoriyuki Konno; Yusuke Nakano; Yoshio Koyanagi
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

Review 9.  Immunological tolerance as a barrier to protective HIV humoral immunity.

Authors:  Kristin Ms Schroeder; Amanda Agazio; Raul M Torres
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

10.  Myelography in patients with acquired immuno deficiency syndrome. Indications and results.

Authors:  B J Borgstein; P A Koster; P Portegies; F L Peeters
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.